4D Molecular Therapeutics Inc (FDMT)
Healthcare
Biotechnology
—
10.20 $
+1.0%
vs. previous close
Closing price · As of: 31. Jul 2026
4D Molecular Therapeutics Inc (FDMT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -109 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 8.2 | -16 | -37 | -51 | -69 | -87 | -76 | -135 | -109 | |
| 0.6 | 0.7 | 1.0 | 1.4 | 3.0 | 3.9 | 5.7 | 6.7 | 7.6 | |
| 0.3 | 1.4 | 3.5 | 5.0 | 14 | 17 | 20 | 26 | 22 | |
| 0.3 | 1.4 | 8.7 | 5.1 | 15 | 17 | – | – | – | |
| 19 | -8.8 | 0.3 | -0.7 | -16 | -1.3 | 0.6 | 0.5 | 6.2 | |
| 0.6 | 0.4 | 3.2 | 1.0 | 9.1 | 12 | 2.8 | 3.8 | 0.5 | |
| 7.7 | -0.4 | -3.2 | -1.0 | -173 | -17 | 116 | -302 | -93 | |
| – | – | -2.3 | -278 | 115 | -0.5 | – | – | 7.5 | |
| 0.0 | 85 | -2.2 | 279 | 118 | 3.1 | 157 | 337 | 113 | |
| 16 | 68 | -42 | 227 | -124 | -101 | 197 | -100 | -89 | |
| 7.7 | -17 | -40 | -52 | -78 | -98 | -79 | -138 | -109 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.